메뉴 건너뛰기




Volumn 5, Issue 2, 2013, Pages 73-75

Is there a need for a formulary of clinically interchangeable medicines to guide generic substitution in Saudi Arabia?

Author keywords

Formulary; Generic medicines; Generic substitution

Indexed keywords

GENERIC DRUG;

EID: 84883451226     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.1016/j.jyp.2013.06.006     Document Type: Article
Times cited : (19)

References (33)
  • 3
    • 33947267465 scopus 로고    scopus 로고
    • Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals
    • K. Andersson, G. Bergstrom, M. Petzold, and A. Carlsten Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals Health Policy. 81 2007 376 384
    • (2007) Health Policy. , vol.81 , pp. 376-384
    • Andersson, K.1    Bergstrom, G.2    Petzold, M.3    Carlsten, A.4
  • 4
    • 78650875380 scopus 로고    scopus 로고
    • GPs save £400m in 2008 by increasing use of generic drugs
    • R. Coombes GPs save £400m in 2008 by increasing use of generic drugs BMJ 338 2009 b2044
    • (2009) BMJ , vol.338 , pp. 2044
    • Coombes, R.1
  • 5
    • 84883465988 scopus 로고    scopus 로고
    • GPhA report: Savings: $1 trillion over 10 years - Generic drug savings in the U.S
    • Generic Pharmaceutical Association
    • Generic Pharmaceutical Association GPhA report: savings: $1 trillion over 10 years - generic drug savings in the U.S J Pharm Health Serv Res 3 2012 229 236
    • (2012) J Pharm Health Serv Res , vol.3 , pp. 229-236
  • 6
    • 84871808597 scopus 로고    scopus 로고
    • Generic Medicines: Essential Contributors to the Long-Term Health of Society
    • Accessed 4.02.13
    • Sheppard A. Generic Medicines: Essential Contributors to the Long-Term Health of Society. IMS Health. Available at: http://www.imshealth.com/imshealth/ Global/Content/Document/Market-Measurement-TL/Generic-Medicines-GA.pdf. Accessed 4.02.13.
    • IMS Health
    • Sheppard, A.1
  • 8
    • 77955576790 scopus 로고    scopus 로고
    • Use of generics - A critical cost containment measure for all healthcare professionals in Europe?
    • B. Godman, W. Shrank, and B. Wettermark Use of generics - a critical cost containment measure for all healthcare professionals in Europe? Pharmaceuticals 3 2010 2470 2494
    • (2010) Pharmaceuticals , vol.3 , pp. 2470-2494
    • Godman, B.1    Shrank, W.2    Wettermark, B.3
  • 10
    • 34249848744 scopus 로고    scopus 로고
    • European Generic Medicines Association (EGA) Available at: Accessed 18.05.13
    • European Generic Medicines Association (EGA) Frequently Asked Questions About Generic Medicines 2007 Available at: http://198.170.119.137/doc/FAQ- generics.pdf Accessed 18.05.13
    • (2007) Frequently Asked Questions about Generic Medicines
  • 11
    • 77951806024 scopus 로고    scopus 로고
    • Creating sustainable European health-care systems through the increased use of generic medicines: A policy analysis
    • S. Simoens Creating sustainable European health-care systems through the increased use of generic medicines: a policy analysis J Generic Med: Business J Generic Med Sec 7 2010 131 137
    • (2010) J Generic Med: Business J Generic Med Sec , vol.7 , pp. 131-137
    • Simoens, S.1
  • 12
    • 84874824355 scopus 로고    scopus 로고
    • The impact of pharmaceutical pricing and reimbursement policies on generics uptake: Implementation of policy options on generics in 29 European countries-an overview
    • S. Vogler The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries-an overview GaBI J 1 2012 93 100
    • (2012) GaBI J , vol.1 , pp. 93-100
    • Vogler, S.1
  • 13
    • 77953722299 scopus 로고    scopus 로고
    • Controversy over generic substitution
    • R.E. Ferner, W. Lenney, and J.F. Marriott Controversy over generic substitution BMJ 340 2010 c3570
    • (2010) BMJ , vol.340 , pp. 3570
    • Ferner, R.E.1    Lenney, W.2    Marriott, J.F.3
  • 15
    • 84883453417 scopus 로고    scopus 로고
    • International Society of Drug Bulletins (ISDB) 20(3 (special issue on INN))
    • International Society of Drug Bulletins (ISDB) ISDB Newsletter 2006 20(3 (special issue on INN))
    • (2006) ISDB Newsletter
  • 16
    • 69249239312 scopus 로고    scopus 로고
    • National Prescribing Service Limited (NPS) Available at: Accessed 9.05.13
    • National Prescribing Service Limited (NPS) Generic Medicines: Same Difference? 2006 Available at: http://www.nps.org.au/-data/assets/pdf-file/0020/ 15842/news44-generic-medicines-0206.pdf Accessed 9.05.13
    • (2006) Generic Medicines: Same Difference?
  • 17
    • 77956407438 scopus 로고    scopus 로고
    • National Prescribing Service Limited (NPS) Available at: Accessed 9.05.13
    • National Prescribing Service Limited (NPS) Generic Medicines: Dealing with Multiple Brands 2007 Available at: http://www.nps.org.au/-data/assets/pdf- file/0008/23867/news55-generic-medicines-1207.pdf Accessed 9.05.13
    • (2007) Generic Medicines: Dealing with Multiple Brands
  • 18
    • 77955741424 scopus 로고    scopus 로고
    • Generic and therapeutic substitutions in the UK: Are they a good thing?
    • M.G. Duerden, and D.A. Hughes Generic and therapeutic substitutions in the UK: are they a good thing? Br J Clin Pharmacol 70 2010 335 341
    • (2010) Br J Clin Pharmacol , vol.70 , pp. 335-341
    • Duerden, M.G.1    Hughes, D.A.2
  • 19
    • 84883453084 scopus 로고    scopus 로고
    • U.S. Department of Health and Human Services-FDA/CDER Available at: 32: Accessed 10.01.13
    • U.S. Department of Health and Human Services-FDA/CDER Office of Generic Drugs. Orange Book: Approved Drug Prod Ther Equivalence Evaluations 2012 Available at: 32: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/ UCM071436.pdf Accessed 10.01.13
    • (2012) Office of Generic Drugs. Orange Book: Approved Drug Prod Ther Equivalence Evaluations
  • 20
    • 78649372017 scopus 로고    scopus 로고
    • Generic drugs: The benefits and risks of making the switch
    • P. Lewek, and P. Kardas Generic drugs: the benefits and risks of making the switch J Fam Pract 59 2010 634 640
    • (2010) J Fam Pract , vol.59 , pp. 634-640
    • Lewek, P.1    Kardas, P.2
  • 21
    • 80052808963 scopus 로고    scopus 로고
    • ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: A report of the American College of Cardiology Foundation Clinical Quality Committee
    • D.R. Holmes, J.A. Becker, M.C. Limacher, R.L. Page, and C. Sila ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee Circulation 124 2011 1290 1310
    • (2011) Circulation , vol.124 , pp. 1290-1310
    • Holmes, D.R.1    Becker, J.A.2    Limacher, M.C.3    Page, R.L.4    Sila, C.5
  • 22
    • 84883454028 scopus 로고    scopus 로고
    • Department of Health and Aging Available at: Accessed 20.01.13
    • Department of Health and Aging Australian Government. Schedule of Pharmaceutical Benefits 2013 Available at: http://www.pbs.gov.au/publication/ schedule/2013/01/2013-01-01-pbs-schedule.pdf Accessed 20.01.13
    • (2013) Australian Government. Schedule of Pharmaceutical Benefits
  • 23
    • 84883455284 scopus 로고    scopus 로고
    • Generics substitution in primary care: Summary of the Dutch community pharmacies guidelines
    • L. Grandia, and A. Vulto Generics substitution in primary care: summary of the Dutch community pharmacies guidelines GaBI J 1 2012 102 103
    • (2012) GaBI J , vol.1 , pp. 102-103
    • Grandia, L.1    Vulto, A.2
  • 24
    • 84873918065 scopus 로고    scopus 로고
    • Royal Dutch Pharmacists Association (KNMP) Available at: Accessed 16.05.13
    • Royal Dutch Pharmacists Association (KNMP) Guideline for Generic Substitution 2012 Available at: http://www.knmp.nl/downloads/producten-diensten/ farmacotherapie/handleiding.geneesmiddelsubstitutie.engels.201202.pdf/view Accessed 16.05.13
    • (2012) Guideline for Generic Substitution
  • 25
    • 84883462931 scopus 로고    scopus 로고
    • Saudi Food & Drug Authority (SFDA) Kingdom of Saudi Arabia Available at: Accessed 18.05.13
    • Saudi Food & Drug Authority (SFDA) Kingdom of Saudi Arabia Data Requirements for Human Drugs Submission: Content of the Dossier (Version 1.1) 2011 Available at: http://www.sfda.gov.sa/en/drug/drug-reg/Regulations/ Data%20Requirements%20for%20Human%20Drugs%20Submission%20version%201.1.pdf Accessed 18.05.13
    • (2011) Data Requirements for Human Drugs Submission: Content of the Dossier (Version 1.1)
  • 26
    • 84883446794 scopus 로고    scopus 로고
    • Executive Board of the Health Ministers' Council for GCC States Available at: Accessed 18.05.13
    • Executive Board of the Health Ministers' Council for GCC States The GCC Guidelines for Bioequivalence (version 2.1) 2011 Available at: http://www.sfda.gov.sa/en/drug/drug-reg/Regulations/ GCC%20%20Guidelines%20for%20Bioequivalence-Final%203-2013.pdf Accessed 18.05.13
    • (2011) The GCC Guidelines for Bioequivalence (Version 2.1)
  • 27
    • 84883465208 scopus 로고    scopus 로고
    • Saudi Food & Drug Authority (SFDA) Kingdom of Saudi Arabia Available at: Accessed 18.05.13
    • Saudi Food & Drug Authority (SFDA) Kingdom of Saudi Arabia Registered Drug List 2013 Available at: http://www.sfda.gov.sa/en/drug/Pages/default.aspx Accessed 18.05.13
    • (2013) Registered Drug List
  • 30
    • 70849123179 scopus 로고    scopus 로고
    • Evaluating community pharmacists' perceptions of future generic substitution policy implementation: A national survey from Malaysia
    • C.P. Chong, M.A. Hassali, M.B. Bahari, and A.A. Shafie Evaluating community pharmacists' perceptions of future generic substitution policy implementation: a national survey from Malaysia Health Policy. 94 2010 68 75
    • (2010) Health Policy. , vol.94 , pp. 68-75
    • Chong, C.P.1    Hassali, M.A.2    Bahari, M.B.3    Shafie, A.A.4
  • 31
    • 77950937059 scopus 로고    scopus 로고
    • A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia
    • G.N. Chua, M.A. Hassali, A.A. Shafie, and A. Awaisu A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia Health Policy. 95 2010 229 235
    • (2010) Health Policy. , vol.95 , pp. 229-235
    • Chua, G.N.1    Hassali, M.A.2    Shafie, A.A.3    Awaisu, A.4
  • 32
    • 84876063614 scopus 로고    scopus 로고
    • Generic substitution in Malaysia: Recommendations from a Systematic Review
    • M.A. Hassali, J. Thambyappa, and F. Saleem Generic substitution in Malaysia: recommendations from a Systematic Review J App Pharm Sc 2 2012 159 164
    • (2012) J App Pharm Sc , vol.2 , pp. 159-164
    • Hassali, M.A.1    Thambyappa, J.2    Saleem, F.3
  • 33
    • 80053916376 scopus 로고    scopus 로고
    • Generic and therapeutic substitution: A viewpoint on achieving best practice in Europe
    • A. Johnston, R. Asmar, and B. Dahlöf Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe Br J Clin Pharmacol 72 2011 727 730
    • (2011) Br J Clin Pharmacol , vol.72 , pp. 727-730
    • Johnston, A.1    Asmar, R.2    Dahlöf, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.